Skip to main content
Log in

Effects of pentoxifylline in Adriamycin-induced renal disease in rats

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Tumor necrosis factor-α (TNF-α) is a mediator of inflammation in human and animal renal disease. Pentoxiphylline (PTX) is an inhibitor of TNF-α. In this study we examined the effects of PTX on TNF-α, proteinuria, nitrite production, and apoptosis in an experimental model of Adriamycin (ADR) nephropathy in rats. Rats were divided into four groups: untreated Wistar rats (controls), PTX treatment alone, ADR treatment alone to induce nephropathy, and ADR treatment followed by PTX. ADR treatment followed by PTX treatment prevented the increase in serum TNF-α levels and proteinuria in rats with ADR-nephropathy (P<0.05). Urine nitrite levels were significantly increased in the ADR-induced nephropathy group and the increase was prevented in the ADR-induced nephropathy group when they also received PTX. The urine nitrite levels were not different between the PTX-treated group and the untreated control rats. PTX prevented the rise of serum TNF-α in ADR nephropathy rats and a decrease in proteinuria, urine nitrite, and apoptosis in the renal tissue. These findings suggest a beneficial anti-inflammatory effect of PTX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ozen S, Usta Y, Sahin-Erdemli I, Orhan D, Gumusel B, Yang B, Gursoy Y, Tulunay O, Dalkara T, Bakkaloglu A, El-Nahas M (2001) Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant 16:32–38

    Article  CAS  Google Scholar 

  2. Gomez-Chiarri M, Ortiz A, Lerma JL, Lopez-Armada MJ, Mampaso F, Gonzalez E, Egido J (1994) Involvement of tumor necrosis factor and platelet activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70:449–459

    CAS  PubMed  Google Scholar 

  3. Ozen S, Saatci U, Tinaztepe K, Bakkaloglu A, Barut A (1994) Urinary tumor necrosis factor levels in primary glomerulopathies. Nephron 66:291–294

    CAS  PubMed  Google Scholar 

  4. Zabel P, Schade FU, Schlaa M (1993) Inhibition of endogenous TNF formation by pentoxyfylline. Immunobiology 187:447–463

    CAS  PubMed  Google Scholar 

  5. Belloc F, Jaloustre C, Dumain P, Lacombe F, Lenoble M, Boisseau MR (1995) Effect of pentoxyfylline on apoptosis of cultured cells. Cardiovasc Pharmacol [Suppl] 2:S71–S74

    Google Scholar 

  6. Lauterbach R, Grabowska A, Marcinkiewicz J (1995) Effect of pentoxifylline on nitric oxide released by murine macrophages. Biol Neonate 67:72–76

    CAS  PubMed  Google Scholar 

  7. Chien-Chen Tsai, Ming-Shiou Wu, Tun-Jun Tsai (1999) Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int 56:932–943

    Article  PubMed  Google Scholar 

  8. Ducloux D, Bresson-Vautrin C, Chalopin J (2001) Use of pentoxifylline in membranous nephropathy. Lancet 357:1672–1673

    Article  CAS  PubMed  Google Scholar 

  9. Baud L, Ardaillou R (1995) Tumor necrosis factor in renal injury. Miner Electrolyte Metab 21:336–341

    Google Scholar 

  10. Poljakovic M, Nygren JM, Persson K (2003) Signalling pathways regulating inducible nitric oxide synthase expression in human kidney epithelial cells. Eur J Pharmacol 23:21–28

    Article  Google Scholar 

  11. Amore A, Coppo R (2000) Role of apoptosis in pathogenesis and progression of renal diseases. Nephron 86:99–104

    Article  CAS  Google Scholar 

  12. Meldrum KK, Burnett AL, Meng X, Misseri R, Shaw MB, Gearhart JP, Meldrum DR (2003) Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 92:293–299

    Google Scholar 

  13. Meldrum KK, Meldrum DR, Hile KL, Yerkes EB, Ayala A, Cain MP, Rink RC, Casale AJ, Kaefer MA (2001) P38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Cell Physiol 281:C563–C570

    CAS  Google Scholar 

  14. Kim YK, Choi TR, Kwon CH, Kim JH, Woo JS, Jung JS (2003) Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure rabbits. Ren Fail 25:909–922

    Article  CAS  Google Scholar 

  15. Chen YM, Ng YY, Lin SL, Chiang WC, Lan HY, Tsai TJ (2004) Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats. Nephrol Dial Transplant (available online)

  16. Lin SL, Chen YM, Chien CT, Chiang WC, Tsai CC, Tsai TJ (2002) Pentoxifylline attenuated the renal disease progression in rats with remnant kidney. J Am Soc Nephrol 13:2916–2929

    CAS  PubMed  Google Scholar 

  17. Galindo-Rodriguez G, Bustamante R, Esquivel-Nava G, Salazar-Exaire D, Vela-Ojeda J, Vadillo-Buenfil M, Avina-Zubieta JA (2003) Pentoxifyllin in the treatment of refractory nephrotic syndrome secondary to lupus nephritis. J Rheumatol 30:2382–2384

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seza Ozen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Usta, Y., Ismailoglu, U.B., Bakkaloglu, A. et al. Effects of pentoxifylline in Adriamycin-induced renal disease in rats. Pediatr Nephrol 19, 840–843 (2004). https://doi.org/10.1007/s00467-004-1538-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-004-1538-5

Keywords

Navigation